Publicaciones últimos 5 años

13. “Glucocorticoids uncover a critical role for ASH2L on BCL-X expression regulation in leukemia cells”, Rocha-Viegas, L*; Silbermins, M; Ogara, MF; Pellegrini, JM; Nuñez, SY; García, VE; Vicent, GP and Pecci, A. Biochim Biophys Acta Gene Regul Mech. Volume 1863, Issue 1, January 2020, 194475, 2019 Dec 20:194475. doi: 10.1016/ j.bbagrm.2019.194475 *Autora correspondiente

12. Murine HO-1 gene induction by ACTH in adrenal cells is mediated by a cAMP response element and involves the activity of PKA and PI3K. Astort F, Repetto EM, Rocha-Viegas L, Mercau ME, Puch SS, Finkielstein CV, Pecci A, Cymeryng C. J Mol Endocrinol. 2016 Aug;57(2):113-24.

11. Runx1 and Foxp3 interplay regulates expression of breast cancer related genes. María S Recouvreux, Esteban N Grasso, Pablo N Echeverria, Luciana Rocha-Viegas, Lucio Castilla, Carolina Shere-Levy, Edith C Kordon and Natalia Rubinstein. Oncotarget. 2016 Feb 9;7(6):6552-65.

10. Role of 3′-5′-cyclic Adenosine Monophosphate on the Epidermal Growth Factor Dependent Survival in Mammary Epithelial Cells. Grinman DY, Romorini L, Presman DM, Rocha-Viegas L, Coso OA, Davio C, Pecci A. Mol Cell Endocrinol. 2016 Jan 5;419:259-67.

9. Role of UTX in RAR-mediated gene regulation in leukemia. Rocha-Viegas L, Villa R,Gutierrez A, Iriondo O, Shiekhattar R, Di Croce L. Mol Cell Biol, 2014 Oct 1;34(19):3765-75.


8. Progesterone Receptor induces bcl-x expression through intragenic binding sites favoring RNA Polymerase II elongation. Bertucci, P; Nacht, A; Alló, M; Rocha-Viegas, L; Ballare, C; Castellano, G; Zaurin, R; Kornblihtt, A; Beato, M; Vicent, G and Pecci. Nucleic Acids Res. 2013 Jul 1;41(12):6072-86

7. Glucocorticoid alternative effects on proliferating and differentiated mammary epithelium are associated to opposite regulation of cell-cycle inhibitor expression. HoijmanE, Rocha-ViegasL, KalkoS, RubinsteinN, Morales-RuizM, Bal de Kier JofféE, KordonE and PecciA. J Cell Physiol. 2012 Apr;227(4):1721-30

6. Transcriptional activation of polycomb-repressed genes by ZRF1. Richly H, Rocha-Viegas L, Domingues Ribeiro J, Demajo S, Gundem G, Lopez Bigas N, Nakagawa T, Rospert S, Ito T and Di Croce L. Nature 2010 468,1124–1128

5. Mechanisms involved in tissue-specific apoptosis regulated by glucocorticoids. Viegas LR, Hoijman E, Beato M, Pecci A. J Steroid Biochem Mol Biol. 2008 109, 273-278

4. Glucocorticoids repress bcl-X expression in lymphoid cells by recruiting STAT5B to the P4 promoter. Rocha-Viegas L, Vicent GP, Barañao JL, Beato M, Pecci A. J Biol Chem. 2006 Nov 10;281(45):33959-70

3. Steroid hormones induce bcl-X gene expression through direct activation of distal promoter P4. Viegas LR, Vicent GP, Barañao JL, Beato M, Pecci A. J Biol Chem. 2004 Mar 12;279(11):9831-9

2. Involvement of Bax protein in the prevention of glucocorticoid-induced thymocytes apoptosis by melatonin. Hoijman E, Rocha Viegas L, Keller Sarmiento MI, Rosenstein RE, Pecci A. Endocrinology. 2004 Jan;145(1):418-25

1. Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene. Pecci A, Viegas LR, Baranao JL, Beato M. J Biol Chem. 2001 Jun 15;276(24):21062-9.